Seeing further.

THAT’S OUR TARGET

We’re advancing our RNA-based treatments so patients with cancers and rare diseases can enjoy the moments that matter.

Learn More

Transforming Immunity. Restoring Hope.

We’re committed to redefining the treatment of certain cancers and rare diseases.

Learn More

Scientists. Believers. People.

At Idera, we’re working hard to translate our nucleic acid science into life-changing medicines.

Discover Idera

The Latest

Keep up with what’s happening at Idera Pharmaceuticals.

News

Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metastatic Melanoma

- 3 Patients with PD-1 Refractory Cutaneous Melanoma are Responders Including One Complete… Read more 

Idera Pharmaceuticals Presents the Novel Mechanism of Action of its Third Generation Antisense Technology

Presentation to be made at Cold Springs Harbor Laboratory Conference on Regulatory &… Read more 

Idera to Present at the 2016 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass. and EXTON, Pa., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc.… Read more 

Learn More

Events

Mon, 26 Sep 2016 17:19:52 GMT

Idera Pharmaceuticals, Inc. Calendar Events

A Collection of Idera Pharmaceuticals, Inc. Calendar Events… Read more 

Learn More